Gorringe AR - Search Results

1

Antibody responses to individual Bordetella pertussis fimbrial antigen Fim2 or Fim3 following immunization with the five-component acellular pertussis vaccine or to pertussis disease.

Alexander F, Matheson M, Fry NK, Labram B, Gorringe AR. Alexander F, et al. Among authors: gorringe ar. Clin Vaccine Immunol. 2012 Nov;19(11):1776-83. doi: 10.1128/CVI.00355-12. Epub 2012 Sep 5. Clin Vaccine Immunol. 2012. PMID: 22956654 Free PMC article.

2

Serospecific protection of mice against intranasal infection with Bordetella pertussis.

Robinson A, Gorringe AR, Funnell SG, Fernandez M. Robinson A, et al. Among authors: gorringe ar. Vaccine. 1989 Aug;7(4):321-4. doi: 10.1016/0264-410x(89)90193-x. Vaccine. 1989. PMID: 2573215

3

Agglutinogens and fimbriae of Bordetella pertussis.

Ashworth LA, Robinson A, Funnell S, Gorringe AR, Irons LI, Seabrook RN. Ashworth LA, et al. Among authors: gorringe ar. Tokai J Exp Clin Med. 1988;13 Suppl:203-10. Tokai J Exp Clin Med. 1988. PMID: 2908520

4

Human antibody response to meningococcal transferrin binding proteins: evidence for vaccine potential.

Gorringe AR, Borrow R, Fox AJ, Robinson A. Gorringe AR, et al. Vaccine. 1995 Sep;13(13):1207-12. doi: 10.1016/0264-410x(95)00055-6. Vaccine. 1995. PMID: 8578805

5

Recombinant Neisseria meningitidis transferrin binding protein A protects against experimental meningococcal infection.

West D, Reddin K, Matheson M, Heath R, Funnell S, Hudson M, Robinson A, Gorringe A. West D, et al. Infect Immun. 2001 Mar;69(3):1561-7. doi: 10.1128/IAI.69.3.1561-1567.2001. Infect Immun. 2001. PMID: 11179327 Free PMC article.

6

Formulation and characterisation of Bordetella pertussis fimbriae as novel carrier proteins for Hib conjugate vaccines.

Crowley-Luke A, Reddin K, Gorringe A, Hudson MJ, Robinson A. Crowley-Luke A, et al. Vaccine. 2001 May 14;19(25-26):3399-407. doi: 10.1016/s0264-410x(01)00074-3. Vaccine. 2001. PMID: 11348704

7

The development of a meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Gorringe A, Halliwell D, Matheson M, Reddin K, Finney M, Hudson M. Gorringe A, et al. Vaccine. 2005 Mar 18;23(17-18):2210-3. doi: 10.1016/j.vaccine.2005.01.055. Vaccine. 2005. PMID: 15755597

8

Proteomic analysis of Neisseria lactamica and N eisseria meningitidis outer membrane vesicle vaccine antigens.

Vaughan TE, Skipp PJ, O'Connor CD, Hudson MJ, Vipond R, Elmore MJ, Gorringe AR. Vaughan TE, et al. Among authors: gorringe ar. Vaccine. 2006 Jun 19;24(25):5277-93. doi: 10.1016/j.vaccine.2006.03.013. Epub 2006 Mar 23. Vaccine. 2006. PMID: 16682101

9

Phase I safety and immunogenicity study of a candidate meningococcal disease vaccine based on Neisseria lactamica outer membrane vesicles.

Gorringe AR, Taylor S, Brookes C, Matheson M, Finney M, Kerr M, Hudson M, Findlow J, Borrow R, Andrews N, Kafatos G, Evans CM, Read RC. Gorringe AR, et al. Clin Vaccine Immunol. 2009 Aug;16(8):1113-20. doi: 10.1128/CVI.00118-09. Epub 2009 Jun 24. Clin Vaccine Immunol. 2009. PMID: 19553555 Free PMC article. Clinical Trial.

10

Nasopharyngeal colonization by Neisseria lactamica and induction of protective immunity against Neisseria meningitidis.

Evans CM, Pratt CB, Matheson M, Vaughan TE, Findlow J, Borrow R, Gorringe AR, Read RC. Evans CM, et al. Among authors: gorringe ar. Clin Infect Dis. 2011 Jan 1;52(1):70-7. doi: 10.1093/cid/ciq065. Clin Infect Dis. 2011. PMID: 21148522

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

98 results

Search Page